With the possibility of Bain Capital and Dr Reddy s entry in the race to acquire promoter s stake in Cipla, competition has now intensified as firms like Torrent Pharma and Blackstone have already placed their respective bids
Private equity firm Bain Capital has approached Indian pharmaceutical company Dr Reddy s Laboratories (DRL) to explore a joint bid for the promoters of Cipla, the Hamied family. DRL is evaluating the opportunity and countering an offer from Torrent Pharma, another Indian investor. If DRL decides to participate, the combined entity would become the leading Indian-origin pharma major at home and in the US and emerging markets.